Adaptive Biotechnologies ADPT
NASDAQ ADPT
$23.95 -0.07 (-0.29%)
At close: Oct 19, 2026 · 4:00 PM EDT

Adaptive Biotechnologies (ADPT) Restructuring Costs (2024 - 2026)

Updated

Adaptive Biotechnologies (ADPT) posted Restructuring Costs of $643,000 for Q1 2026.

Analysis

Adaptive Biotechnologies (ADPT) Restructuring Costs (2024 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Restructuring Costs at Adaptive Biotechnologies was $923,000, down 3.9% year-over-year; for FY2024, it was $2 million.

  • The Q1 2026 figure stands as the highest quarterly Restructuring Costs since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 100.51 Bn 96.52 Bn -
2 Natera 57.27 Bn 52.95 Bn 485.19 Mn
3 Quest Diagnostics 26.09 Bn 24.22 Bn 1.03 Bn
4 Labcorp Holdings 26.08 Bn 23.83 Bn 1.11 Bn
5 Tenet Healthcare 22.29 Bn 11.30 Bn -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.78 Bn 4.73 Bn 1.52 Bn
8 BrightSpring Health Services 12.65 Bn 10.98 Bn 492.75 Mn
9 Davita 12.13 Bn 9.34 Bn 1.16 Bn
10 Adaptive Biotechnologies 3.82 Bn 2.82 Bn 51.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 643,000.00
Dec 31, 2024 87,000.00
Sep 30, 2024 193,000.00
Jun 30, 2024 680,000.00
Mar 31, 2024 1.04 Mn
API Access

Adaptive Biotechnologies Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ADPT&period=max&api_key=YOUR_API_KEY